Hsbc Holdings PLC purchased a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 1,139,486 shares of the financial services provider’s stock, valued at approximately $211,804,000. Hsbc Holdings PLC owned about 0.24% of Marsh & McLennan Companies as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently bought and sold shares of the business. Solstein Capital LLC bought a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at about $25,000. SHP Wealth Management purchased a new stake in shares of Marsh & McLennan Companies in the 4th quarter worth approximately $26,000. KERR FINANCIAL PLANNING Corp bought a new position in shares of Marsh & McLennan Companies during the fourth quarter valued at approximately $27,000. Golden State Wealth Management LLC purchased a new position in Marsh & McLennan Companies during the fourth quarter valued at approximately $27,000. Finally, Atlas Capital Advisors Inc. bought a new position in Marsh & McLennan Companies in the fourth quarter worth approximately $28,000. Institutional investors own 87.99% of the company’s stock.
Marsh & McLennan Companies Stock Performance
Shares of NYSE MRSH opened at $178.13 on Friday. The company has a market cap of $86.05 billion, a price-to-earnings ratio of 22.27, a price-to-earnings-growth ratio of 2.60 and a beta of 0.61. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.28. Marsh & McLennan Companies, Inc. has a 12 month low of $156.60 and a 12 month high of $216.32.
Insiders Place Their Bets
In other news, CEO John Q. Doyle sold 16,656 shares of the stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the sale, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $18,889,506.81. This represents a 12.48% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts have issued reports on MRSH shares. Mizuho dropped their target price on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating on the stock in a research report on Monday, April 13th. Bank of America decreased their price objective on Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating for the company in a research note on Tuesday, April 14th. UBS Group dropped their price objective on Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating on the stock in a research report on Tuesday, June 9th. Piper Sandler reduced their target price on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a report on Tuesday, May 26th. Finally, Barclays decreased their price target on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $200.19.
Read Our Latest Report on Marsh & McLennan Companies
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Further Reading
- Five stocks we like better than Marsh & McLennan Companies
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
